US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tevogen Bio Holdings

1.24

+0.140012.73%

Post-market: 1.22-0.0200-1.61%19:58 EDT

Volume:1.06M

Turnover:1.34M

Market Cap:228.03M

PE:-6.05

High:1.32

Open:1.16

Low:1.16

Close:1.10

Loading ...

Overview Company News Filings

Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital

Tevogen Bio Holdings Inc. CEO Ryan H. Saadi Reports Disposal of Common Shares

Tevogen expands headquarters in Warren, New Jersey

Tevogen Bio to Relocate R&D Center Employees to Expanded Warren, NJ Headquarters by June 2025

Tevogen details AI initiative, Tevogen.AI, with Microsoft, Databricks pacts

Tevogen Details Its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy With Microsoft and Databricks Partnerships

THOMSON REUTERS

Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital

Tevogen announces planned expansion of TVGN 489’s target population

Tevogen Bio Expands Target Population to Include Seniors, Projects Nearly $1 Billion in First-Year Revenue

Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital

Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest

Biotech Alert: Searches spiking for these stocks today

Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts

BRIEF-Tevogen CEO To Join Dialogue On Paths To Liquidity at BioNJ’s Fifteenth Annual Bio Partnering Conference

Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at Bionj’s Fifteenth Annual Bio Partnering Conference With Experts From J.p. Morgan, Rsm, and Cantor Fitzgerald

THOMSON REUTERS

Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald

Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital

BUZZ-Tevogen gains after it reaffirms revenue forecast for experimental oncology drugs

Tevogen sees launch year oncology business revenue $1B

Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TVGN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGN\",,,,,undefined,":{"symbol":"TVGN","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings","latestPrice":1.24,"timestamp":1749585600000,"preClose":1.1,"halted":0,"volume":1062870,"hourTrading":{"tag":"盘后","latestPrice":1.22,"preClose":1.24,"latestTime":"19:58 EDT","volume":22586,"amount":27811.7104,"timestamp":1749599916127},"delay":0,"floatShares":18880265,"shares":183893433,"eps":-0.204889,"marketStatus":"Not Yet Opened","change":0.14,"latestTime":"06-10 16:00:00 EDT","open":1.16,"high":1.3191,"low":1.16,"amount":1336273.963266,"amplitude":0.144636,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.204889,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749628800000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":1.1,"preHourTrading":{"tag":"盘前","latestPrice":1.2,"preClose":1.1,"latestTime":"09:29 EDT","volume":132660,"amount":162832.840434,"timestamp":1749562199999},"postHourTrading":{"tag":"盘后","latestPrice":1.22,"preClose":1.24,"latestTime":"19:58 EDT","volume":22586,"amount":27811.7104,"timestamp":1749599916127},"volumeRatio":0.841264},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGN\",,,,,undefined,":{"symbol":"TVGN","floatShares":18880265,"roa":"-578.29%","roe":"--","lyrEps":-0.070045,"volumeRatio":0.841264,"shares":183893433,"dividePrice":0,"high":1.3191,"amplitude":0.144636,"preClose":1.1,"low":1.16,"week52Low":0.2556,"pbRate":"-13.80","week52High":3.09,"institutionHeld":0,"latestPrice":1.24,"eps":-0.204889,"divideRate":0,"volume":1062870,"delay":0,"ttmEps":-0.204889,"open":1.16,"prevYearClose":1.03,"prevWeekClose":1.43,"prevMonthClose":1.29,"prevQuarterClose":1.08,"fiveDayClose":1.28,"twentyDayClose":1.19,"sixtyDayClose":1.17},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TVGN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542864319","title":"Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2542864319","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542864319?lang=en_us&edition=fundamental","pubTime":"2025-06-10 19:23","pubTimestamp":1749554580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TVGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 10, 2025 07:23 ET (11:23 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN"],"gpt_icon":0},{"id":"2542935550","title":"Tevogen Bio Holdings Inc. CEO Ryan H. Saadi Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2542935550","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542935550?lang=en_us&edition=fundamental","pubTime":"2025-06-10 07:14","pubTimestamp":1749510853,"startTime":"0","endTime":"0","summary":"Ryan H. Saadi, who is the Chief Executive Officer and a Director of Tevogen Bio Holdings Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tevogen Bio Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDL8VGWgh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Tevogen Bio Holdings Inc. CEO Ryan H. Saadi Reports Disposal of Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TVGN"],"gpt_icon":0},{"id":"2542387284","title":"Tevogen expands headquarters in Warren, New Jersey","url":"https://stock-news.laohu8.com/highlight/detail?id=2542387284","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542387284?lang=en_us&edition=fundamental","pubTime":"2025-06-09 21:15","pubTimestamp":1749474926,"startTime":"0","endTime":"0","summary":"Tevogen (TVGN) announced the execution of a lease agreement to expand its corporate headquarters in Warren, New Jersey, more than doubling its foot...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-expands-headquarters-in-warren-new-jersey-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-expands-headquarters-in-warren-new-jersey-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2540709347","title":"Tevogen Bio to Relocate R&D Center Employees to Expanded Warren, NJ Headquarters by June 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2540709347","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540709347?lang=en_us&edition=fundamental","pubTime":"2025-06-04 01:46","pubTimestamp":1748972808,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc. has announced plans to relocate employees from its Philadelphia research and development center to its expanded principal executive offices in Warren, New Jersey. This move follows the expiration of the current lease in Philadelphia in June 2025. The relocation comes after Tevogen Bio Inc., a subsidiary of Tevogen Bio Holdings, amended its lease to double the office space at the New Jersey location and extend the lease term until February 2033.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tevogen Bio Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL6trtdh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2539768672","title":"Tevogen details AI initiative, Tevogen.AI, with Microsoft, Databricks pacts","url":"https://stock-news.laohu8.com/highlight/detail?id=2539768672","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539768672?lang=en_us&edition=fundamental","pubTime":"2025-05-30 23:10","pubTimestamp":1748617825,"startTime":"0","endTime":"0","summary":"Tevogen (TVGN) provided stockholders a detailed overview of its artificial intelligence initiative, Tevogen.AI, aimed at integrating advanced machi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-details-ai-initiative-tevogen-ai-with-microsoft-databricks-pacts-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-details-ai-initiative-tevogen-ai-with-microsoft-databricks-pacts-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1066051811.HKD","LU1043141396.HKD","SGXZ81514606.USD","BK4503","LU1670711123.USD","IE000W1ABFV2.USD","BK4581","LU2108987350.USD","LU1815333072.USD","LU2404859667.USD","LU0061474705.USD","BK4504","LU0553294199.USD","LU0097036916.USD","IE00B4JS1V06.HKD","IE00BLSP4239.USD","GB00B4QBRK32.GBP","IE0034235188.USD","LU2764262908.HKD","LU0788109477.HKD","LU2191332357.HKD","LU1697837992.HKD","LU0011850046.USD","LU2097344357.USD","LU2413666699.HKD","TVGN","LU0820562030.AUD","LU0689626769.HKD","IE00B3SWFQ91.USD","LU0198837287.USD","LU1582987597.SGD","BK4097","LU0950375773.USD","LU0323239441.USD","IE00BWXC8680.SGD","IE0004445239.USD","LU2092937148.SGD","LU2452424414.USD","LU0124676726.USD","LU0545039389.USD","IE00BK4W5M84.HKD","IE00BYQQ9H92.USD","LU0314104364.USD","IE0004091025.USD","SG9999015341.SGD","IE00BHPRN162.USD","LU1235295455.SGD","LU2456880835.USD","LU2028103732.USD"],"gpt_icon":0},{"id":"2539754592","title":"Tevogen Details Its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy With Microsoft and Databricks Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2539754592","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539754592?lang=en_us&edition=fundamental","pubTime":"2025-05-30 23:01","pubTimestamp":1748617278,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nTUA7VJJTW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1989772923.USD","LU1127390331.HKD","LU1069344957.HKD","LU2089283258.USD","BK4097","IE00BFXG0V08.USD","LU0061474705.USD","IE000YTNTUN2.SGD","LU2063271972.USD","LU0157215616.USD","LU0950375773.USD","BK4525","LU2452424414.USD","LU1720051017.SGD","LU1235295455.SGD","LU2506952097.USD","SG9999002232.USD","LU1064131342.USD","BK4543","LU1046421795.USD","BK4538","LU1366192091.USD","LU0894486033.HKD","LU0347712357.USD","BK4567","LU2097344357.USD","TVGN","LU0149725797.USD","LU2083900584.USD","TVGNW","LU1803068623.USD","LU2023250504.SGD","LU2092937221.SGD","IE00BYXW3230.USD","LU2125154935.USD","LU1712237335.SGD","LU1623119135.USD","LU0345774391.USD","LU0162691827.USD","LU1261432733.SGD","LU0708994859.HKD","LU2403377893.USD","LU1043141396.HKD","LU2506952170.USD","IE00B19Z8W00.USD","LU2111349929.HKD","LU2237438978.USD","MSFT","BK4612","LU2028103732.USD"],"gpt_icon":0},{"id":"2538465698","title":"Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2538465698","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538465698?lang=en_us&edition=fundamental","pubTime":"2025-05-27 19:49","pubTimestamp":1748346540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TVGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 27, 2025 07:49 ET (11:49 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN"],"gpt_icon":0},{"id":"2537154194","title":"Tevogen announces planned expansion of TVGN 489’s target population","url":"https://stock-news.laohu8.com/highlight/detail?id=2537154194","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537154194?lang=en_us&edition=fundamental","pubTime":"2025-05-24 03:55","pubTimestamp":1748030120,"startTime":"0","endTime":"0","summary":"Tevogen (TVGN) announced a planned expansion of TVGN 489’s target population to include patients 65 and older. Tevogen Bio’s Chief Commercial Offic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-announces-planned-expansion-of-tvgn-489s-target-population-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-announces-planned-expansion-of-tvgn-489s-target-population-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2537415469","title":"Tevogen Bio Expands Target Population to Include Seniors, Projects Nearly $1 Billion in First-Year Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2537415469","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537415469?lang=en_us&edition=fundamental","pubTime":"2025-05-24 03:50","pubTimestamp":1748029809,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc., trading on Nasdaq under the ticker symbol TVGN, has announced plans to expand its specialty care pipeline to include patients aged 65 and older, building on a previous revenue forecast of nearly $1 billion in its launch year. The cumulative five-year revenue estimate for Tevogen's specialty pharmaceuticals is projected to range between $18 billion and $22 billion. This expansion is set to enhance the market potential of the company's offerings. An updated forecast and the risk-adjusted net present value  will be released to reflect the inclusion of the 65+ patient demographic. In response to the detection of the more contagious COVID variant NB.1.8.1 in the U.S., initially identified in China, Tevogen Bio is prioritizing the expansion of clinical manufacturing capacity to meet significant unmet medical needs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and time","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL3MKTsN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","NDAQ"],"gpt_icon":0},{"id":"2534396275","title":"Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2534396275","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534396275?lang=en_us&edition=fundamental","pubTime":"2025-05-12 21:33","pubTimestamp":1747056780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TVGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 12, 2025 09:33 ET (13:33 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN"],"gpt_icon":0},{"id":"2532871819","title":"Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2532871819","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532871819?lang=en_us&edition=fundamental","pubTime":"2025-05-03 03:45","pubTimestamp":1746215100,"startTime":"0","endTime":"0","summary":"WARREN, N.J., May 02, 2025  -- Tevogen   today announced that, following the Company’s recent press release highlighting the Direct Registration System  as a secure method of share ownership, it has received a number of inquiries from shareholders seeking additional information on how to transfer their shares to a DRS account.In response, Tevogen will provide step-by-step guidance early next week to help interested shareholders register their shares directly with the Company’s transfer agent, Continental Stock Transfer & Trust.The Company also notes that several of its largest shareholders, both internal and external, have elected to hold their shares via DRS, underscoring their confidence in this method of direct ownership.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tevogen-share-direct-registration-system-194500249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B7SZL793.SGD","DRS","IE00B19Z4B17.USD","TVGN","IE0031619046.USD","TVGNW","IE00B66KJ199.SGD","BK4187"],"gpt_icon":0},{"id":"2532000582","title":"Biotech Alert: Searches spiking for these stocks today","url":"https://stock-news.laohu8.com/highlight/detail?id=2532000582","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532000582?lang=en_us&edition=fundamental","pubTime":"2025-05-02 00:15","pubTimestamp":1746116123,"startTime":"0","endTime":"0","summary":"These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include:. Discover companies with rock-solid fundamentals in  TipRanks' Smart Value Newsletter.Receive undervalued stocks, resilient to market uncertainty,  delivered straight to your inbox.Tevogen Bio Holdings , 332% surge in interest. Pipeline and key clinical candidates for these companies:. Galmed is a clinical stage biopharmaceutical company focused on the development of Aramchol for liver and fibro-inflammatory diseases. The company has focused almost exclusively on developing Aramchol for the treatment of noncirrhotic nonalcoholic steatohepatitis, or NASH, and are currently developing Aramchol for Primary Sclerosing Cholangitis, or PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of liver disease.CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commer","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biotech-alert-searches-spiking-stocks-161523387.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-alert-searches-spiking-stocks-161523387.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MKKGY","SWTX","IE00B2B36J28.USD","IE0009355771.USD","SNTI","BK4578","TVGNW","BCDA","BK4539","IE00BJT1NW94.SGD","BK4007","BK4139","IE00BJJMRZ35.SGD","BK4588","BK4585","GLMD","LU0211331839.USD","NVS","TVGN","LU0070302665.USD","LU0208291251.USD","BK4532","RGLS","BCDAW","CGON","IE0002141913.USD","IE00BFTCPJ56.SGD","CMMB","LU0320765489.SGD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2531726767","title":"Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts","url":"https://stock-news.laohu8.com/highlight/detail?id=2531726767","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531726767?lang=en_us&edition=fundamental","pubTime":"2025-04-30 01:48","pubTimestamp":1745948880,"startTime":"0","endTime":"0","summary":"WARREN, N.J., April 29, 2025  -- Tevogen  , today informed shareholders about several differences between holding shares in Direct Registration System  accounts and holding them in brokerage accounts.A DRS account is an alternative to using a brokerage account and Tevogen encourages shareholders to explore the differences. DRS accounts ensure your shares are registered directly in your name and not held through intermediary brokers, allowing shareholder to exercise direct control over their shares. DRS accounts may also have reduced transaction and account maintenance costs for shareholders. Brokerage accounts may provide greater access to tools, and selling shares in this type of account may be quicker when compared to a DRS account. Investors may also incur certain costs in connection with transferring shares in and out of a brokerage account.For more information about these and other differences, please contact the Company’s transfer agent, Continental Stock Transfer & Trust.Tevogen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tevogen-informs-public-shareholders-drs-174800183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4187","DRS","IE00B7SZL793.SGD","IE00B66KJ199.SGD","TVGNW","IE0031619046.USD","IE00B19Z4B17.USD","TVGN"],"gpt_icon":0},{"id":"2531739891","title":"BRIEF-Tevogen CEO To Join Dialogue On Paths To Liquidity at BioNJ’s Fifteenth Annual Bio Partnering Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2531739891","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531739891?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:49","pubTimestamp":1745930987,"startTime":"0","endTime":"0","summary":"BRIEF-Tevogen CEO To Join Dialogue On Paths To Liquidity at BioNJ’s Fifteenth Annual Bio Partnering Conference April 29 (Reuters) - JPMorgan Chase & Co JPM.N:TEVOGEN CEO TO JOIN DIALOGUE ON PATHS TO L","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nTUA2BSXTT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002232.USD","LU0976567544.SGD","SG9999002224.SGD","LU1629891620.HKD","IE0034235295.USD","LU2430703251.USD","IE00BKVL7J92.USD","LU0070302665.USD","LU0345769631.USD","IE00BYXW3230.USD","LU0820562030.AUD","IE00BWXC8680.SGD","LU2430703178.SGD","IE000M9KFDE8.USD","LU1267930490.SGD","LU0234572021.USD","BK4585","LU0211326755.USD","IE00B775SV38.USD","BK4588","LU0345769128.USD","IE00BJLML261.HKD","LU0320765646.SGD","LU1894683348.USD","LU0683600562.USD","LU1548497426.USD","LU0496365809.HKD","BK4516","LU2430703095.HKD","LU0787776722.HKD","LU1914381329.SGD","IE00BJTD4V19.USD","IE00BDCRKT87.USD","BK4550","TVGNW","LU0323591593.USD","IE0034235303.USD","LU2054465674.USD","LU0868494617.USD","LU0256863811.USD","LU2237443465.HKD","LU1988902786.USD","BK4581","LU2023250843.SGD","LU0208291251.USD","TVGN","LU2237443895.HKD","LU0211326839.USD","LU0964807845.USD","LU1244550577.SGD"],"gpt_icon":1},{"id":"2531787292","title":"Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at Bionj’s Fifteenth Annual Bio Partnering Conference With Experts From J.p. Morgan, Rsm, and Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2531787292","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531787292?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:00","pubTimestamp":1745928000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nTUA2BSXTT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4207","IE00BFXG1179.USD","IE00BJLML261.HKD","LU2552382132.HKD","LU2023250843.SGD","LU1119994496.HKD","LU2106854487.HKD","LU0943347566.SGD","LU0208291251.USD","LU1145028129.USD","IE00BKVL7J92.USD","IE00BBT3K403.USD","IE00BJTD4V19.USD","LU2237443978.SGD","LU1720051017.SGD","LU1894683348.USD","LU2430703251.USD","LU0976567544.SGD","TVGN","LU0345769128.USD","IE00B1BXHZ80.USD","LU0267386448.USD","LU2237443382.USD","LU1548497426.USD","LU0787776722.HKD","SG9999002232.USD","TVGNW","LU1261432733.SGD","LU1551013425.SGD","IE00BKDWB100.SGD","LU0203345920.USD","LU0683600562.USD","BK4585","IE00BZ1G4Q59.USD","LU2592432038.USD","LU0345769631.USD","LU0320765646.SGD","LU1363072403.SGD","LU0211326839.USD","LU0496365809.HKD","IE00BN8TJ469.HKD","LU2242649171.HKD","LU1032466523.USD","LU1917777945.USD","BK4534","LU1670628061.USD","LU2505996509.AUD","LU0238689110.USD","BK4533","LU0310799852.SGD"],"gpt_icon":0},{"id":"2531339647","title":"Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2531339647","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531339647?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:00","pubTimestamp":1745928000,"startTime":"0","endTime":"0","summary":"WARREN, N.J., April 29, 2025  -- Tevogen  , today reminds that CEO Dr. Ryan Saadi MD, MPH will participate in BioNJ’s Fifteenth Annual Bio Partnering Conference. Dr. Saadi will be featured on the panel discussion titled Paths to Liquidity: Strategies for Adapting to a Volatile Market, moderated by David C Schwartz, Partner at Morgan Lewis. Along with Dr. Ryan Saadi, the panel will also include commentary from Matt Vamvakis, MBA, Managing Director, J.P. Morgan Private Bank, Amanda Laskey, Life Sciences Senior Analyst, RSM US, and Kee Colon, MBA, Managing Director, Cantor Fitzgerald.“The conference’s action-packed agenda, featuring 1:1 partnering sessions, company pitch presentations, the Industry Connections Desk, exhibits, extensive networking opportunities and engaging plenary discussions, was thoughtfully designed to provide entrepreneurs with a dynamic environment geared toward growth and collaboration,” said BioNJ President and CEO Debbie Hart. “With that in mind, we’re thrilled to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tevogen-ceo-join-dialogue-paths-120000040.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2531782825","title":"Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2531782825","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531782825?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:38","pubTimestamp":1745926680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TVGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 29, 2025 07:38 ET (11:38 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN"],"gpt_icon":0},{"id":"2531826960","title":"BUZZ-Tevogen gains after it reaffirms revenue forecast for experimental oncology drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2531826960","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531826960?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:57","pubTimestamp":1745873831,"startTime":"0","endTime":"0","summary":"BUZZ-Tevogen gains after it reaffirms revenue forecast for experimental oncology drugs** Shares of drug developer Tevogen TVGN.O up 49.35% at $1.40 in after-market trading** Company reaffirms top-line revenue forecast for its experimental oncology drugs** Projects $1 billion in revenue in its launch year and a cumulative 5-year estimate of between $10 billion and $14 billion** Stock down 9% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL4N3R61S9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN"],"gpt_icon":0},{"id":"2531269463","title":"Tevogen sees launch year oncology business revenue $1B","url":"https://stock-news.laohu8.com/highlight/detail?id=2531269463","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531269463?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:50","pubTimestamp":1745873433,"startTime":"0","endTime":"0","summary":"Tevogen (TVGN) reaffirms its top-line revenue forecast for its oncology pipeline, projecting $1B in revenue in its launch year and a cumulative fiv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-sees-launch-year-oncology-business-revenue-1b?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-sees-launch-year-oncology-business-revenue-1b?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TVGN"],"gpt_icon":0},{"id":"2531652752","title":"Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2531652752","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531652752?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:36","pubTimestamp":1745872617,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nTUA7Q52VY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":67,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"TVGN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-02-15","symbol":"TVGN","reason":null,"defaultRemindTime":1708007400000,"announcedDate":"2024-02-14","type":"delisting","dateTimestamp":1707973200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1741924800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TVGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TVGN","date":"2025-06-09","current":-7.437018,"percent":0.786184,"low":-87.683882,"twenty":-32.112758,"median":-18.297627,"eighty":-7.231389,"high":-2.106753,"avg":-21.738717,"sd":15.950945,"marketCap":262967609},"quantilePoints":[{"date":"2024-03-01","current":-58.029616,"twenty":-57.969868,"median":-57.58151,"eighty":-55.109463,"marketCap":1279054027},{"date":"2024-03-08","current":-55.116932,"twenty":-57.969868,"median":-57.3948,"eighty":-55.049716,"marketCap":1214854404},{"date":"2024-03-15","current":-48.544723,"twenty":-57.715942,"median":-55.116932,"eighty":-49.664986,"marketCap":1069993717},{"date":"2024-03-22","current":-31.890149,"twenty":-57.596447,"median":-52.465643,"eighty":-44.108482,"marketCap":702903564},{"date":"2024-03-28","current":-25.919148,"twenty":-57.357457,"median":-49.38492,"eighty":-32.983824,"marketCap":571294337},{"date":"2024-04-05","current":-25.392625,"twenty":-55.998205,"median":-48.543977,"eighty":-28.607629,"marketCap":559689021},{"date":"2024-04-12","current":-18.446995,"twenty":-55.146806,"median":-35.064227,"eighty":-23.267262,"marketCap":406597612},{"date":"2024-04-19","current":-15.833048,"twenty":-54.915285,"median":-32.71989,"eighty":-19.118705,"marketCap":348982566},{"date":"2024-04-26","current":-6.348156,"twenty":-53.503754,"median":-29.329228,"eighty":-17.595595,"marketCap":139922255},{"date":"2024-05-03","current":-7.365355,"twenty":-52.428301,"median":-25.919148,"eighty":-15.026459,"marketCap":162342739},{"date":"2024-05-10","current":-2.698495,"twenty":-50.822591,"median":-23.061357,"eighty":-9.708944,"marketCap":163198734},{"date":"2024-05-17","current":-2.422494,"twenty":-49.291565,"median":-20.164731,"eighty":-7.316959,"marketCap":146506832},{"date":"2024-05-24","current":-2.231961,"twenty":-48.694091,"median":-18.372311,"eighty":-2.71254,"marketCap":134983822},{"date":"2024-05-31","current":-2.106753,"twenty":-48.544425,"median":-17.961548,"eighty":-2.656034,"marketCap":127411559},{"date":"2024-06-07","current":-8.033143,"twenty":-47.558444,"median":-17.550785,"eighty":-2.656034,"marketCap":148265257},{"date":"2024-06-14","current":-7.903098,"twenty":-44.108482,"median":-15.833048,"eighty":-2.68298,"marketCap":145865070},{"date":"2024-06-21","current":-6.795171,"twenty":-36.221832,"median":-12.47226,"eighty":-2.696046,"marketCap":125416385},{"date":"2024-06-28","current":-6.570165,"twenty":-35.295748,"median":-12.322891,"eighty":-2.697026,"marketCap":121263525},{"date":"2024-07-05","current":-6.173255,"twenty":-33.757254,"median":-8.033143,"eighty":-2.703177,"marketCap":113937879},{"date":"2024-07-12","current":-6.299258,"twenty":-33.071802,"median":-7.830197,"eighty":-2.721904,"marketCap":116263481},{"date":"2024-07-15","current":-6.435162,"twenty":-32.983824,"median":-7.830197,"eighty":-2.721904,"marketCap":118771808},{"date":"2024-08-02","current":-5.57114,"twenty":-32.895846,"median":-7.830197,"eighty":-2.721904,"marketCap":102824824},{"date":"2024-08-09","current":-5.526139,"twenty":-32.222045,"median":-7.468419,"eighty":-3.563104,"marketCap":101994252},{"date":"2024-08-16","current":-20.612899,"twenty":-30.545833,"median":-7.468046,"eighty":-4.127144,"marketCap":122353801},{"date":"2024-08-23","current":-17.275162,"twenty":-29.265149,"median":-7.830197,"eighty":-4.681198,"marketCap":102541700},{"date":"2024-08-30","current":-14.308285,"twenty":-28.407028,"median":-7.866648,"eighty":-5.281333,"marketCap":84930944},{"date":"2024-09-06","current":-12.936966,"twenty":-27.171154,"median":-9.617885,"eighty":-5.454137,"marketCap":76791088},{"date":"2024-09-13","current":-14.230663,"twenty":-25.708539,"median":-12.097501,"eighty":-5.499138,"marketCap":84470197},{"date":"2024-09-20","current":-12.649478,"twenty":-24.871927,"median":-12.454498,"eighty":-5.544139,"marketCap":75084620},{"date":"2024-09-27","current":-11.784139,"twenty":-23.267262,"median":-12.36199,"eighty":-5.658262,"marketCap":69948149},{"date":"2024-10-04","current":-8.756889,"twenty":-21.942215,"median":-12.240382,"eighty":-5.887588,"marketCap":51979034},{"date":"2024-10-11","current":-9.208245,"twenty":-21.329829,"median":-12.040003,"eighty":-6.069393,"marketCap":54658190},{"date":"2024-10-18","current":-39.673363,"twenty":-24.871927,"median":-12.127687,"eighty":-6.141394,"marketCap":235492672},{"date":"2024-10-25","current":-73.596963,"twenty":-29.393307,"median":-12.327491,"eighty":-6.173255,"marketCap":436855971},{"date":"2024-10-31","current":-70.722082,"twenty":-31.779361,"median":-12.436737,"eighty":-6.180635,"marketCap":419791285},{"date":"2024-11-08","current":-32.773648,"twenty":-33.757254,"median":-12.633666,"eighty":-6.224556,"marketCap":194537424},{"date":"2024-11-15","current":-42.548244,"twenty":-38.983392,"median":-12.936966,"eighty":-6.285578,"marketCap":252557358},{"date":"2024-11-22","current":-36.270609,"twenty":-39.155884,"median":-13.187081,"eighty":-6.299438,"marketCap":287084045},{"date":"2024-11-29","current":-28.972255,"twenty":-38.235922,"median":-13.602501,"eighty":-6.300158,"marketCap":229317133},{"date":"2024-12-06","current":-23.222036,"twenty":-37.373458,"median":-13.816575,"eighty":-6.348156,"marketCap":183803809},{"date":"2024-12-13","current":-22.337387,"twenty":-36.270609,"median":-14.269474,"eighty":-6.435162,"marketCap":176801759},{"date":"2024-12-20","current":-21.33331,"twenty":-36.221832,"median":-15.004006,"eighty":-6.508963,"marketCap":168854432},{"date":"2024-12-27","current":-23.222036,"twenty":-35.303209,"median":-15.833048,"eighty":-6.557925,"marketCap":183803809},{"date":"2025-01-03","current":-23.443198,"twenty":-34.373394,"median":-17.065337,"eighty":-6.580965,"marketCap":185554321},{"date":"2025-01-10","current":-28.52993,"twenty":-33.790638,"median":-17.550785,"eighty":-6.670967,"marketCap":225816108},{"date":"2025-01-17","current":-26.760632,"twenty":-33.439732,"median":-17.684618,"eighty":-6.873653,"marketCap":211812008},{"date":"2025-01-24","current":-30.52039,"twenty":-33.171426,"median":-18.032197,"eighty":-7.005548,"marketCap":241570720},{"date":"2025-01-31","current":-29.635741,"twenty":-33.528197,"median":-18.446995,"eighty":-7.075423,"marketCap":234568670},{"date":"2025-02-07","current":-31.405039,"twenty":-33.171426,"median":-19.295444,"eighty":-7.138439,"marketCap":248572770},{"date":"2025-02-14","current":-34.501311,"twenty":-33.892862,"median":-20.164731,"eighty":-7.192457,"marketCap":273079945},{"date":"2025-02-21","current":-34.280148,"twenty":-34.280148,"median":-20.612899,"eighty":-7.244366,"marketCap":271329432},{"date":"2025-02-28","current":-27.645281,"twenty":-34.280148,"median":-21.570546,"eighty":-7.365355,"marketCap":218814058},{"date":"2025-03-07","current":-24.327847,"twenty":-34.058986,"median":-22.031836,"eighty":-7.370735,"marketCap":192556371},{"date":"2025-03-14","current":-24.54901,"twenty":-33.906622,"median":-22.226806,"eighty":-7.443187,"marketCap":194306884},{"date":"2025-03-21","current":-25.875983,"twenty":-33.837824,"median":-22.558549,"eighty":-7.452187,"marketCap":204809958},{"date":"2025-03-28","current":-26.53947,"twenty":-33.616662,"median":-23.000874,"eighty":-7.454567,"marketCap":210061496},{"date":"2025-04-04","current":-13.396106,"twenty":-33.174337,"median":-23.222036,"eighty":-7.467672,"marketCap":183893433},{"date":"2025-04-11","current":-13.396106,"twenty":-33.15978,"median":-22.669131,"eighty":-7.468419,"marketCap":183893433},{"date":"2025-04-17","current":-13.664028,"twenty":-32.994496,"median":-22.447968,"eighty":-7.468419,"marketCap":187571301},{"date":"2025-04-25","current":-13.530067,"twenty":-32.809553,"median":-22.063146,"eighty":-7.757841,"marketCap":185732367},{"date":"2025-05-02","current":-13.10675,"twenty":-32.74034,"median":-21.917772,"eighty":-7.830197,"marketCap":179921334},{"date":"2025-05-09","current":-14.601755,"twenty":-32.722315,"median":-21.231576,"eighty":-7.830197,"marketCap":200443841},{"date":"2025-05-16","current":-5.980818,"twenty":-32.552659,"median":-20.228412,"eighty":-7.830197,"marketCap":211477447},{"date":"2025-05-23","current":-6.396875,"twenty":-32.510851,"median":-19.566511,"eighty":-7.465051,"marketCap":226188922},{"date":"2025-05-30","current":-6.968954,"twenty":-32.378153,"median":-18.686729,"eighty":-7.414206,"marketCap":246417200},{"date":"2025-06-06","current":-7.333003,"twenty":-32.156991,"median":-18.297627,"eighty":-7.218412,"marketCap":259289740},{"date":"2025-06-09","current":-7.437018,"twenty":-32.112758,"median":-18.297627,"eighty":-7.231389,"marketCap":262967609}],"updateTime":1749588852358}}}